Saturday 17 October 2026
Export YTENQ’s income statement to Excel — free account
Metabolix, Inc.
YTENQ Basic Materials Agricultural Inputs
Metabolix, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $60,000.00, down 86.7% from fiscal 2022. Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow YTENQ
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 3 | 4 | 4 | 4 | 2 | 2 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(44.56) | (28.27) | (39.22) | (31.45) | (35.93) | (24.28) | (72.80) | (161.45) |
P/S ratio |
8.43 | 7.09 | 14.90 | 3.10 | 17.19 | 37.94 | 18.70 | 5.54 |
Altman Z″-Score (non-manufacturers) |
(102.88) | (60.81) | (90.14) | (71.10) | (82.79) | (56.89) | (168.33) | (376.59) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(4.04) | (3.53) | (4.10) | (0.78) | (6.90) | (9.38) | (2.75) | (1.17) |
Beneish M-Score |
(0.87) | (3.22) | 4.13 | (3.98) | (2.79) | (2.08) | (4.83) | — |
P/B ratio |
1.53 | 0.53 | 1.45 | 0.00 | 1.44 | 1.45 | 1.91 | 0.00 |
Price to Tangible BV |
1.53 | 0.53 | 1.45 | 0.00 | 1.44 | 1.45 | 1.91 | 0.00 |
EV/Sales |
3.10 | (7.16) | 14.64 | (6.20) | 9.00 | 16.22 | 13.65 | 5.27 |
EV/EBITDA |
0.00 | 0.74 | 0.00 | 0.60 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.25) | 0.82 | (0.93) | 0.58 | (0.83) | (1.08) | (0.54) | (0.19) |
EV/FCF |
(0.24) | 0.79 | (0.93) | 0.57 | (0.82) | (1.05) | (0.53) | (0.19) |
Quick Ratio |
2.72 | 6.15 | 3.61 | 5.08 | 5.41 | 9.34 | 2.72 | 0.22 |
Current Ratio |
2.85 | 6.28 | 3.89 | 5.29 | 5.70 | 9.59 | 3.12 | 0.29 |
Net Debt/EBITDA |
0.63 | 1.60 | 0.63 | 1.32 | 1.03 | 1.39 | 0.33 | 0.08 |
Debt/Assets |
10.53% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.08 | 0.07 | 0.04 | 0.05 | 0.05 | 0.04 | 0.03 | 0.01 |
Operating CF/Net income |
1.89 | 0.76 | 0.95 | 0.67 | 0.85 | 0.84 | 0.84 | 0.70 |
Capex/Depreciation |
(1.46) | (0.03) | (0.21) | (0.30) | (0.36) | (0.86) | (0.59) | (0.16) |
| (78.40%) | (113.61%) | (99.93%) | (1,606.45%) | (374.74%) | (86.32%) | (132.83%) | (1,508.09%) | |
| (54.63%) | (78.34%) | (61.56%) | (87.31%) | (65.34%) | (63.15%) | (95.20%) | (241.08%) | |
ROIC |
(3,335.94%) | 0.00% | 0.00% | 0.00% | 0.00% | (20,298.61%) | (15,862.03%) | 0.00% |
Return on Tangible Assets |
(111.15%) | (76.86%) | (150.06%) | (120.86%) | (108.01%) | (69.90%) | (324.31%) | 495.54% |
Average Days of Receivables |
59.21 | 46.01 | 105.04 | 41.66 | 51.62 | 117.70 | 24.33 | 0.00 |
Research and Development Expense of Revenue |
489.21% | 486.97% | 860.25% | 601.49% | 670.96% | 1,009.93% | 1,722.22% | 13,871.67% |
Selling, General and Administrative Expense of Revenue |
495.00% | 596.40% | 915.83% | 565.01% | 631.66% | 994.30% | 1,366.89% | 10,256.67% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
73.17% | 147.78% | 212.41% | 81.39% | 92.49% | 272.80% | 422.89% | 2,653.33% |
Graham Net Nets |
0.36 | 1.72 | (0.11) | (3.64) | 0.39 | 0.53 | 0.16 | (2.49) |
Graham Number |
0.00 | 0.00 | 0.00 | 2,277.61 | 0.00 | 0.00 | 0.00 | 91.71 |
Earnings Yield |
(82.56%) | (157.92%) | (111.96%) | (521.07%) | (81.25%) | (47.52%) | (161.27%) | (825.83%) |
Free Cash Flow Yield |
(155.10%) | (128.09%) | (106.15%) | (348.25%) | (63.53%) | (40.53%) | (137.38%) | (505.43%) |
Revenue per Share |
399.66 | 277.65 | 53.46 | 53.03 | 8.07 | 3.11 | 2.20 | 0.18 |
Operating CF per Share |
(4,966.90) | (2,412.35) | (841.73) | (569.34) | (87.46) | (46.90) | (55.63) | (30.39) |
Capex per Share |
(259.31) | (1.76) | (4.04) | (4.01) | (0.67) | (0.96) | (0.75) | (0.14) |
Free Cash Flow per Share |
(5,226.21) | (2,414.12) | (845.77) | (573.36) | (88.13) | (47.86) | (56.38) | (30.53) |
Cash per Share |
2,520.34 | 4,260.88 | 554.71 | 731.38 | 98.00 | 81.04 | 21.20 | 3.22 |
Shareholders Equity per Share |
2,196.21 | 3,971.18 | 547.88 | (268.75) | 96.28 | 81.23 | 21.46 | (7.49) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2,196.21 | 3,971.18 | 547.88 | (268.75) | 96.28 | 81.23 | 21.46 | (7.49) |
Free Cash Flow |
(15.16) | (8.21) | (8.80) | (8.71) | (8.72) | (9.44) | (11.56) | (10.11) |
Working Capital |
5.10 | 12.54 | 4.74 | 9.48 | 8.53 | 14.89 | 3.41 | (3.46) |
Capital Expenditures |
(0.75) | (0.01) | (0.04) | (0.06) | (0.07) | (0.19) | (0.15) | (0.05) |
Net Current Asset Value |
3.48 | 11.54 | (0.88) | (9.12) | 5.35 | 12.24 | 1.33 | (4.99) |
EV/EBIT |
0.00 | 0.73 | 0.00 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.65 | 0.01 | 0.08 | 0.08 | 0.08 | 0.31 | 0.34 | 0.77 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.30 | 0.13 | 0.14 | 0.16 | 0.20 | 0.25 | 0.34 | 0.53 |
Cash ROIC |
(102.34%) | (29.33%) | (76.71%) | (123.93%) | (45.36%) | (29.49%) | (132.14%) | 714.77% |
Accounts Receivable Turnover |
3.21 | 6.15 | 3.99 | 6.40 | 7.80 | 3.95 | 3.95 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | — | — | — | — | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | — | — | — | — | 0.00 | 0.00 | — |
Average Receivables |
0.36 | 0.15 | 0.14 | 0.13 | 0.10 | 0.16 | 0.11 | — |
Average Payables |
0.09 | 0.07 | 0.10 | 0.20 | 0.17 | 0.07 | 0.10 | 0.66 |
Average Inventory |
0.12 | — | — | — | — | — | — | — |
Average Assets |
13.92 | 13.82 | 14.92 | 14.84 | 15.62 | 17.47 | 14.25 | 6.00 |
Average Common Equity |
9.70 | 9.53 | 9.19 | 0.81 | 2.72 | 12.78 | 10.21 | 0.96 |
Columns are period end dates